5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole
C19H20FN5OS — CID 133475120
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole
5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole (PubChem CID 133475120) has the molecular formula C19H20FN5OS and a molecular weight of 385.47 g/mol. Its IUPAC name is 5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 133475120 |
| Molecular Formula | C19H20FN5OS |
| Molecular Weight | 385.47 g/mol |
| Exact Mass | 385.14 |
| IUPAC Name | 5-cyclopropyl-3-[1-[5-[(2-fluorophenyl)methyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]-1,2,4-oxadiazole |
| SMILES | Fc1ccccc1Cc1nnc(N2CCC(c3noc(C4CC4)n3)CC2)s1 |
| InChI | InChI=1S/C19H20FN5OS/c20-15-4-2-1-3-14(15)11-16-22-23-19(27-16)25-9-7-12(8-10-25)17-21-18(26-24-17)13-5-6-13/h1-4,12-13H,5-11H2 |
| InChIKey | BOFGWVMNORTUBF-UHFFFAOYSA-N |
| XLogP | 3.91 |
| TPSA | 67.94 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.47 |
| LogP ≤ 5 | 3.91 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 133475120 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.